ENABLE INJECTIONS
Enable Injections designs, manufactures, and sells wearable delivery devices for injectable drugs. The Enable Injections products can deliver drugs directly from standard vials supplied by all pharmaceutical companies, can reconstitute powdered drugs into liquids as a part of the injection procedure, can inject very viscous drugs, and can inject up to 20 ml. Such products are called bolus injection systems. No other existing drug delivery device can accomplish all of these tasks. For inquiries, ... telephone and contact numbers are used. Approximately 900 new drugs are being developed that may require bolus injection technology like that being developed by Enable Injections. The total market is expected to reach $8 billion within ten years. Partisan principals have supplied 10% of the seed capital to Enable Injections. It also delivers a controlled flow of up to 50 ml of a biologic through an automatically inserted needle. Enable Injections also offers a version of the drug delivery platform that may connect to smartphones via Bluetooth. It also utilizes any standard container closure system, including syringes or vials; automatically warms and can automatically mix lyophilized solutions. Enable Injections was founded in 2010 and is headquartered in Cincinnati, Ohio, USA.
ENABLE INJECTIONS
Industry:
Health Care Life Science Manufacturing Medical Device
Founded:
2011-01-01
Address:
Cincinnati, Ohio, United States
Country:
United States
Website Url:
http://www.enableinjections.com
Total Employee:
101+
Status:
Active
Contact:
+1 513 326 2800
Email Addresses:
[email protected]
Total Funding:
347 M USD
Technology used in webpage:
Domain Not Resolving Person Schema Gravatar Profiles Microsoft Java EE Microsoft Azure Google Adsense Express Google Adsense Asynchronous 3 To 9 CcTLD Redirects
Similar Organizations
AEGEA Medical
AEGEA Medical manufactures surgical and medical instruments.
Aerobiotix
Aerobiotix is a privately held company specializing in the development and manufacture of proprietary environmental management devices.
Atomo Diagnostics
Atomo Diagnostics design and manufactures blood-based, lateral flow rapid diagnostic test (RDT) devices.
Axio Biosolutions
Axio is a medtech R&D and Manufacturing Company focused on Advanced surgical and woundcare products based on novel biomaterials.
Basecare
Basecare is a manufacturing devices for embryonic pre-implantation genetic screening.
BiVACOR
BiVACOR designs and manufactures centrifugal heart pumps.
Circadiance
Circadiance develops, manufactures, and markets respiratory products for people with sleep-disordered breathing
Common Sensing
Common Sensing develops and manufactures data-driven hardware and software solutions for people using injectable medicine.
Corindus
Corindus develops and commercializes remote robotic systems for interventional procedures.
Dynaleo
Dynaleo manufactures cannabis-infused gummies for the adult-use market.
Embolx
Embolx is a medical device start-up that manufactures and sells novel embolization microcatheters to treat cancer.
Wellsense
Wellsense develops and manufactures medical devices to provide hospitals to enhance their standard of care.
EON Aligner
EON Aligner is a practically invisible and removable alternative to traditional braces.
Ezra Innovations
Ezra Innovations develops, manufactures and offers drug delivery technology and equipment.
Eva
Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks.
Kerecis
Kerecis develops, manufactures, and markets implants and repair materials for the human body from omega3 rich fish skin.
LumiThera
LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease.
Metric Medical Devices
Metric Medical Devices develops, manufactures, and distributes orthopedic implant systems for musculoskeletal fixation.
Recovery Force
Recovery Force is a developer and manufacturer of MORPH, an on-body pre recovery and performance enhancement system.
Vivani Medical
Vivani Medical manufactures and markets implantable visual prosthetics to enable blind individuals to achieve greater independence.
Simplify Medical
Simplify Medical designs, develops, and manufactures cervical artificial discs for use in the spine.
Spine Wave
Spine Wave engages in developing and marketing medical devices for the treatment of spinal disorders.
TearLab
TearLac Corporation develops lab-on-a-chip technologies, enabling eye care practitioners to test for disease markers at the point-of-care.
ThermiAesthetics
ThermiAesthetics is a developer and manufacturer of thermistor-regulated energy systems for plastic surgery and dermatology applications.
Unilife Corporation
Unilife is a U.S-based medical device and technology company that designs, develops, manufactures and supplies innovative.
Wright Therapy Products
Wright Therapy Products develops compression therapy devices for the treatment of lymphedema and venous insufficiency.
ZPower
ZPower is a developer of rechargeable, silver-zinc batteries for microbattery applications.
Current Advisors List
Current Employees Featured
Founder
Investors List
Wood Creek Capital Management
Wood Creek Capital Management investment in Series C - Enable Injections
Squarepoint Capital
Squarepoint Capital investment in Series C - Enable Injections
Cincinnati Childrenโs
Cincinnati Childrenโs investment in Series C - Enable Injections
Magnetar Capital
Magnetar Capital investment in Series C - Enable Injections
GCM Grosvenor
GCM Grosvenor investment in Series C - Enable Injections
CincyTech
CincyTech investment in Series C - Enable Injections
Cintrifuse
Cintrifuse investment in Series C - Enable Injections
Ohio Innovation Fund
Ohio Innovation Fund investment in Series C - Enable Injections
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Enable Injections
Partisan Management Group
Partisan Management Group investment in Series B - Enable Injections
Newest Events participated
Official Site Inspections
http://www.enableinjections.com Semrush global rank: 4.28 M Semrush visits lastest month: 2.7 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Enable Injections" on Search Engine
Enable Injections | High-Volume Wearable Drug Delivery Systems
Enable Injections specializes in high-volume wearable drug delivery systems. Creators of the enFuse® On-Body Platform.See details»
About: Our Mission and History | Enable Injections
Learn more about Enable Injections, makers of the enFuse on-body infusor. View our mission, history, and recent industry awards and recognition in the digital healthcare field.See details»
Enable Injections - Crunchbase Company Profile & Funding
Organization. Enable Injections. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. About. Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication. Cincinnati, Ohio, United States. 101-250. Series C. Private. โฆSee details»
Our Mission: Empowering Patients | Enable Injections
Enable Injections is committed to developing and manufacturing innovative drug delivery systems that satisfy Customer and Regulatory requirements, and to maintain the effectiveness of the Quality Management System. Certifications. ISO 13485:2016.See details»
Enable Injections, Inc. | LinkedIn
Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience.See details»
Fierce Medtech Names Enable Injections a "Fierce 15" Company โฆ
CINCINNATI, March 5, 2024 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse ® platform of wearable technology, today announced...See details»
Enable Injections: innovating to share in the success of ... - Nature
Enable Injections is a combination product company that is synonymous with large-volume wearable injectors. When biopharma companies want to make their biologics more convenient for patients,...See details»
Enable Injections Receives First U.S. Food and Drug โฆ
CINCINNATI, Oct. 2, 2023 /PRNewswire/ -- Enable Injections, Inc. ("Enable") today announced that the U.S. Food and Drug Administration (FDA) has approved the EMPAVELI Injector (enFuse ®) for...See details»
Enable Injections Company Profile - Craft
$215 M. Company Summary. Overview. Enable Injections is a company developing and manufacturing on-body subcutaneous drug delivery systems. Its body-worn enFuse drug delivery platform utilizes standard container closure systems to deliver high-volume pharmaceutical and biologic therapeutics.See details»
Series C - Enable Injections - 2022-01-27 - Crunchbase
Jan 27, 2022 Overview. Organization Name. Enable Injections. Announced Date Jan 27, 2022. Funding Type Series C. Funding Stage Late Stage Venture. Money Raised. $215M. Lead Investors. Magnetar Capital Magnetar Capital is an alternative asset manager that structures its investments to be profitable across a wide range of outcomes. Investors.See details»
Enable Injections: Our Story and Team Culture
Enable Injections is a Cincinnati-based investigational-stage company developing and manufacturing novel on-body injection systems designed to support improved outcomes, patient experience, and healthcare system value.See details»
Enable Injections Achieves ISO Certification to Meet Mounting โฆ
Enable Injections, Inc., developer of the advanced enFuse large volume wearable injectors (LVWI) platform for subcutaneous delivery of biologics, has been awarded the International Organization for Standardizationโs 13485:2016 certification for its โฆSee details»
Enable Injections Enters into Strategic Partnerships with UCB and ...
On Nov 14, 2018. Enable Injections announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB. Enable Injections currently has partnerships with five companies to deliver products that shift treatment to the home with easy, convenient self-administration of new large-volume drugs.See details»
Careers: Enable Injections | Learn More โฆ
Enable Injections is made up of a team passionate about working together to make peopleโs lives better. We develop, manufacture, and support the enFuse®, a platform of wearable infusion devices designed to enable subcutaneous self-administration of high-volume therapeutics.See details»
Enable Injections to expand manufacturing facility in Ohio
Feb 14, 2024 Enable Injections plans for its new 90,000-square-foot manufacturing center to support ongoing in-house manufacturing and supply of its enFuse medicine delivery technology. The company develops the enFuse platform, which allows hands-free, hidden needle drug delivery of up to 25 mL.See details»
Enable Injections Receives First U.S. Food and Drug โฆ
CINCINNATI, Oct. 2, 2023 /PRNewswire/ -- Enable Injections, Inc. ("Enable") today announced that the U.S. Food and Drug Administration (FDA) has approved the EMPAVELI Injector (enFuse ®) for...See details»
Enable Injections Announces Plans to Expand Manufacturing โฆ
CINCINNATI, Feb. 14, 2024 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse ® platform of wearable technology, today announced...See details»
Enable Injections - Funding, Financials, Valuation & Investors
$347M. in funding over 8 rounds. Their latest funding was raised on Jan 27, 2022 from a Series C round. Enable Injections is funded by 12 investors. Wood Creek Capital Management and Squarepoint Capital are the most recent investors. Enable Injections has a post-money valuation in the range of $500M to $1B as of Jan 27, 2022, according to โฆSee details»
Board of Directors | Enable Injections
Learn about Enable Injections' distinguished Board of Directors. Comprised of seven industry experts.See details»
Enable Injections Receives First U.S. Food and Drug ... - BioSpace
CINCINNATI, Oct. 2, 2023 /PRNewswire/ -- Enable Injections, Inc. ("Enable") today announced that the U.S. Food and Drug Administration (FDA) has approved the EMPAVELI Injector (enFuse ®) for the subcutaneous delivery of EMPAVELI ® (pegcetacoplan), which is commercialized in the United States by Apellis Pharmaceuticals, Inc. for adults with parox...See details»